These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8724316)

  • 21. [Risk of hemorrhage in the knee joint following intraarticular injections].
    Heilmann HH; Teichmüller HJ; Walther HU; Regling G; Lindenhayn K
    Z Rheumatol; 1987; 46(6):317-21. PubMed ID: 3439366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hylan versus corticosteroid versus placebo for treatment of basal joint arthritis: a prospective, randomized, double-blinded clinical trial.
    Heyworth BE; Lee JH; Kim PD; Lipton CB; Strauch RJ; Rosenwasser MP
    J Hand Surg Am; 2008 Jan; 33(1):40-8. PubMed ID: 18261664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nociceptive nerve activity in an experimental model of knee joint osteoarthritis of the guinea pig: effect of intra-articular hyaluronan application.
    Gomis A; Miralles A; Schmidt RF; Belmonte C
    Pain; 2007 Jul; 130(1-2):126-36. PubMed ID: 17197090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of clinical response to intraarticular Hylan injections -- a prospective study using synovial fluid measures, clinical outcomes, and magnetic resonance imaging.
    Anandacoomarasamy A; Bagga H; Ding C; Burkhardt D; Sambrook PN; March LM
    J Rheumatol; 2008 Apr; 35(4):685-90. PubMed ID: 18278831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hylan G-F 20 tolerability with repeat treatment in a large orthopedic practice: a retrospective review.
    Waddell DD; Bricker DC
    J Surg Orthop Adv; 2006; 15(1):53-9. PubMed ID: 16603113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of hylan G-F 20 after knee arthroscopy in an active patient population with knee osteoarthritis.
    Zietz PM; Selesnick H
    Arthroscopy; 2008 Apr; 24(4):416-22. PubMed ID: 18375273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis.
    Waddell DD; Cefalu CA; Bricker DC
    Curr Med Res Opin; 2003; 19(6):499-507. PubMed ID: 14594522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acute local reaction to intra-articular infiltration with synvisc (Hylan GF20). About two cases].
    Noáin E; Sáncez-Villares JJ; Lasanta PJ; González Arteaga FJ
    An Sist Sanit Navar; 2003; 26(2):283-5. PubMed ID: 12951623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synvisc perisynovitis.
    Zardawi IM; Chan I
    Pathology; 2001 Nov; 33(4):519-20. PubMed ID: 11827424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of an acute attack of calcium pyrophosphate dihydrate arthritis by intra-articular injection of hylan G-F 20 (Synvisc).
    Kroesen S; Schmid W; Theiler R
    Clin Rheumatol; 2000; 19(2):147-9. PubMed ID: 10791628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan.
    Allard S; O'Regan M
    Clin Ther; 2000 Jun; 22(6):792-5. PubMed ID: 10929925
    [No Abstract]   [Full Text] [Related]  

  • 32. [Viscosuplementation with hyaluronic acid in osteoarthritis treatment--our experiences].
    Stambuk B; Pasalić B
    Reumatizam; 2006; 53(2):95-7. PubMed ID: 17580563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of intra-articular hylan G-F 20 in the treatment of symptomatic osteoarthritis of the shoulder: a preliminary study.
    Silverstein E; Leger R; Shea KP
    Am J Sports Med; 2007 Jun; 35(6):979-85. PubMed ID: 17395958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-articular hyaluronan injections for treatment of osteoarthritis of the knee.
    Tecnologica MAP Suppl; 1998 May; ():6-10. PubMed ID: 10183368
    [No Abstract]   [Full Text] [Related]  

  • 35. Intra-articular hylan G-F 20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK).
    Clarke S; Lock V; Duddy J; Sharif M; Newman JH; Kirwan JR
    Knee; 2005 Jan; 12(1):57-62. PubMed ID: 15664879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudoseptic reactions to Hylan viscosupplementation: diagnosis and treatment.
    Magilavy DB; McPherson JM; Polisson R
    Clin Orthop Relat Res; 2004 Dec; (429):349-50; author reply 350-1. PubMed ID: 15577509
    [No Abstract]   [Full Text] [Related]  

  • 37. Response to: identification of an immunogenic candidate for the elicitation of severe acute inflammatory reactions (SAIRs) to hylan G-F 20.
    Burns JW; Kraines JL; Magilavy DB; Murray CW; Richards SM
    Osteoarthritis Cartilage; 2005 Dec; 13(12):1128-9; author reply 1130-1. PubMed ID: 16165377
    [No Abstract]   [Full Text] [Related]  

  • 38. Knocking out knee pain.
    Harv Womens Health Watch; 1998 Feb; 5(6):7. PubMed ID: 9600048
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of the value of intraarticular Hyalgan injections for treatment of knee joint osteoarthritis].
    Sieliwończyk P; Mazurkiewicz S; Ostojski R; Kusiak A
    Chir Narzadow Ruchu Ortop Pol; 1997; 62(4):337-42. PubMed ID: 9471409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute attack of chondrocalcinosis after an intraarticular injection of hyaluronan.
    Maillefert JF; Hirschhorn P; Pascaud F; Piroth C; Tavernier C
    Rev Rhum Engl Ed; 1997 Oct; 64(10):593-4. PubMed ID: 9385702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.